InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-26.2%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Vacirca Jeff L, Director. Director active across 3 companies, notably SPECTRUM PHARMACEUTICALS INC. Cumulatively, 10 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €32k. Activity tracked since 17 June 2021. The latest transaction was disclosed on 11 June 2024 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
10,000 shares@ US$1.11100.0% of flowCommon StockSEC:0001104659-24-070931:0
Ideal exit: 8 Mar 2025 (T+270)
53,750 shares0Common StockSEC:0001104659-24-065700:0
52,642 sharesCommon StockSEC:0001104659-23-086925:0
295,244 sharesCommon Stock, $0.001 par valueSEC:0000899243-23-017668:0
50,000 shares@ US$0.4544.1% of flowCommon Stock, $0.001 par valueSEC:0000899243-22-037526:0
Ideal exit: 27 Aug 2023 (T+270)
50,000 shares@ US$0.4343.7% of flowCommon Stock, $0.001 par valueSEC:0001209191-22-054744:0
25,000 shares0Common Stock, $0.001 par valueSEC:0001209191-22-048523:0
10,000 shares@ US$0.6849100.0% of flowCommon Stock, $0.001 par valueSEC:0001209191-22-009266:0
14,277 shares0Common Stock, $0.001 par valueSEC:0001209191-21-042495
14,277 shares0Common Stock, $0.001 par valueSEC:0001209191-21-042495:0
10 of 10 declarations
About Vacirca Jeff L
Jeff L. Vacirca is a Board Member at SPECTRUM PHARMACEUTICALS INC. He plays a key role in the governance of the company, contributing to strategic decision-making and performance evaluation.
